GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » Pre-Tax Income

VGI Health Technology (XNEC:VTL) Pre-Tax Income : A$ Mil (TTM As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. VGI Health Technology's pretax income for the six months ended in . 20 was A$0.00 Mil. VGI Health Technology does not have enough years/quarters to calculate the pretax income for the trailing twelve months (TTM) ended in . 20. VGI Health Technology's pretax margin was %.


VGI Health Technology Pre-Tax Income Historical Data

The historical data trend for VGI Health Technology's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology Pre-Tax Income Chart

VGI Health Technology Annual Data
Trend
Pre-Tax Income

VGI Health Technology Semi-Annual Data
Pre-Tax Income

Competitive Comparison of VGI Health Technology's Pre-Tax Income

For the Biotechnology subindustry, VGI Health Technology's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VGI Health Technology's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VGI Health Technology's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where VGI Health Technology's Pre-Tax Income falls into.



VGI Health Technology Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

VGI Health Technology's Pretax Income for the fiscal year that ended in . 20 is calculated as

VGI Health Technology's Pretax Income for the quarter that ended in . 20 is calculated as


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VGI Health Technology  (XNEC:VTL) Pre-Tax Income Explanation

VGI Health Technology's Pretax Margin for the quarter that ended in . 20 is calculated as

Pretax Margin=Pretax Income/Revenue
=/
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VGI Health Technology Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


VGI Health Technology (XNEC:VTL) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003
VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines